The 17th Golden Helix Pharmacogenomics day will be organized in the Queridozaal of the Erasmus University Medical Center in Rotterdam, the Netherlands. The meeting will be co-organized from the Erasmus MC, Department of Clinical Chemistry, the European Pharmacogenomics Implementation Consortium (Eu-PIC), the Dutch Clinical Chemistry Society and the Golden Helix Foundation.
This international event is open for clinical chemists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.
The symposium will take place at Erasmus MC, Wytemanweg 80, Rotterdam in the Querido room of the Educational Center. Rotterdam can be reached from Schiphol airport by high speed train (25 min). From Rotterdam Central station, a taxi can bring you to Erasmus MC, entrance Wytemaweg. For metro, use exit Dijkzigt,which is closest to entrance Wytemaweg. For car, you can use parking Westzeedijk or Museumpark
On behalf of the Organizing Committee
Co-organized by:
Under the auspices of:
IntroductionSpeakersScientific ProgramSponsorsGalleryThe 17th Golden Helix Pharmacogenomics day will be organized in the Queridozaal of the Erasmus University Medical Center in Rotterdam, the Netherlands. The meeting will be co-organized from the Erasmus MC, Department of Clinical Chemistry, the European Pharmacogenomics Implementation Consortium (Eu-PIC), the Dutch Clinical Chemistry Society and the Golden Helix Foundation.
This international event is open for clinical chemists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.
The symposium will take place at Erasmus MC, Wytemanweg 80, Rotterdam in the Querido room of the Educational Center. Rotterdam can be reached from Schiphol airport by high speed train (25 min). From Rotterdam Central station, a taxi can bring you to Erasmus MC, entrance Wytemaweg. For metro, use exit Dijkzigt,which is closest to entrance Wytemaweg. For car, you can use parking Westzeedijk or Museumpark
On behalf of the Organizing Committee
Co-organized by:
Under the auspices of:
Organizing Committee
Ron H. van Schaik, Professor; Erasmus MC, Department of Clinical Chemistry; Coordinator; European Pharmacogenomics Implementation Consortium
George P. Patrinos, Associate Professor; University of Patras School of Health Sciences, Department of Pharmacy, Patras, Greece
Committee Molecular Biology Diagnostics (CMBD) NVKC
Invited speakers and moderators
Joachim Aerts, Rotterdam, NL
Maarten Akkerman, Leusden, NL
Norma Anwar, London, UK
Marieke Coenen, Nijmegen, NL
Vera Deneer, The Hague, NL
Maurizio Ferrari, Milan, IT
Henk-Jan Guchelaar, Leiden, NL,
Linda Henricks, Amsterdam, NL
Tim Hubbard, London, UK
Magnus Ingelman-Sundberg, Stockholm, SE
Julie Johnson, Tampa, FL, USA
Vangelis G. Manolopoulos, Alexandroupolis, GR
Mikko Niemi, Helsinki, FI
George P. Patrinos, Patras, GR
Markus Paulmichl, Salzburg, AT
Marzia del Re, Pisa, IT
Ron van Schaik, Rotterdam, NL
Matthias Schwabb, Stuttgart, DE
Jesse Swen, Leiden, NL
Andre Uitterlinden, Rotterdam, NL
Teun van Gelder, Rotterdam, NL
Emile Voest, Amsterdam, NL
Scientific Program
8:00 Registration
Welcome Addresses
08:45 Ron van Schaik, Professor; Erasmus MC, Department of Clinical Chemistry, Rotterdam, the Netherlands; Coordinator; European Pharmacogenomics Implementation Consortium (Eu-PIC)
08:50 George P. Patrinos, Associate Professor; University of Patras School of Health Sciences, Department of Pharmacy, Patras, Greece
08:55 Maurizio Ferrari, President, International Federation of Clinical Chemistry (IFCC) representative
Session I: Clinical Implementation – Chairs: M. Ferrari, R.H. van Schaik
09:00 – 09:15 Drs Edith Schippers (tbc), Minister of Health
09:15 – 09:40 KEYNOTE LECTURE – Improving clinical outcomes with Pharmacogenomics
Prof. Julie Johnson, University of Florida, Tampa, FL, USA
09:40 – 10:00Implementation of Pharmacogenomics in Austria
Prof. Markus Paulmichl, Paracelsus University, Salzburg, AT
10:00 – 10:20 Sequencing rare variants: the next step in Pharmacogenomics
Prof. Magnus Ingelman-Sundberg, Karolinska Institutet, Stockholm, SE
10:20 – 10:45 COFFEE BREAK
Session II: Evidence for Clinical Use – Chairs: G. P. Patrinos, T. van Gelder
10:45 – 11:05TPMT genotyping for thiopurine treatment
Dr. Marieke Coenen,Radboud University, Nijmegen, NL
11:05 – 11:25 Clinical value of DPYD genotyping
Dr. Linda Henricks, Netherlands Cancer Institute (NKI), Amsterdam, NL
11:25 – 11:45 Tamoxifen and CYP2D6 : where do we stand today?
Prof. Matthias Schwabb, Margarete Fisher Bosch Institute, Stuttgart, DE
11:45 – 12:05 Pharmacogenomics for improving statin treatment
Prof. Mikko Niemi, University of Helsinki, Helsinki, FI
12:05 – 13:00 LUNCH BREAK – Foyer 3rd floor outside Querido room
Session III: Using Pharmacogenomics for Diagnostics – Chairs: J. Swen, M. Paulmichl
13:00 – 13:15 Evidence-based dosing based on genotype
Dr. Vera Deneer, KNMP Pharmacogenomics Working Group, den Haag, NL
13:15 – 13:30 Pharmacogenomics information in drug labels
Dr. Norma Anwar, European Medicine Agency, London, UK
13:30 – 13:45The position of the Health Care Insurer
Dr. Maarten Akkerman, Hospital Care ACHMEA, Leusden, NL
Session IV: Genotyping and Translation – Chairs: Y. B. de Rijke, D. A. v/d Broek
13:45 – 14:00 Using Next Generation Sequencing for Pharmacogenomics
Prof. George P. Patrinos, University of Patras, Department of Pharmacy, Patras. GR
COMPANY LECTURES
14:00 – 14:15 A new tool for pre-emptive pharmacogenetic testing
Dr. Dominique de Wolf, ThermoFisher, BE
14:15 – 14:30Actionable Pharmacogenomics reporting software
Dr. Fareed Kureshy, AUTOGENOMICS, USA
14:30 – 14:45 A portal for reporting Pharmacogenomics results
Prof. Daniela Steinberger, Bio.Logis, DE
14:45 – 15:00Translational tools for Pharmacogenomics results
Dr. Jari Forsstm, Abomics
15:00 – 15:25 TEA BREAK
Session V: Personalized Drug Therapy – Chairs: J. Aerts, A. Uitterlinden
15:25 – 15:50The Genomics England initiative: 100,000 genomes
Prof. Tim Hubbard, Genomics England, London, UK
15:50 – 16:15 Sequencing the tumor genome: the CPCT approach
Dr. Emile Voest, Netherlands Cancer Institute (NKI), Amsterdam, NL
16:15 – 16:40Cell-free DNA analysis for lung and prostate cancer
Dr. Marzia del Re, University of Pisa, Pisa, IT
Session VI: European Initiatives – Chairs: M. Ferrari, V. Deneer
16:40 – 16:55European Society of Pharmacogenomics & Personalized Therapy
Prof. Vangelis G. Manolopoulos, Democritus University of Thrace, Alexandroupolis, GR; Vice-President;European Society of Pharmacogenomics & Personalized Therapy (ESPT)
16:55 – 17:10 European Pharmacogenomics Implementation Consortium
Prof. Ron H. van Schaik, Erasmus MC, Department of Clinical Chemistry, Rotterdam, NL; Coordinator; European Pharmacogenomics Implementation Consortium (Eu-PIC)
17:10 – 17:25 The HORIZON2020 U-PGx project
Prof. Henk-Jan Guchelaar, Leiden University Medical Center, Leiden, NL, Coordinator; UPGx Consortium
17:25 – 17:30 Conclusions and wrap up
Prof. Ron H. van Schaik, Erasmus MC, Department of Clinical Chemistry, Rotterdam, NL; Coordinator; European Pharmacogenomics Implementation Consortium (Eu-PIC)
17:30 Drinks and Networking Opportunity
Sponsors
The Organizing Committee acknowledges the support of following entities that support the organization of the 17th Golden Helix Pharmacogenomics Day:
Sponsors:
